LogoLogoLogoLogoLogo
  • Portfolio
  • News
    • In the News
    • Press Releases
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us
  • Portfolio
  • News
    • In the News
    • Press Releases
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us

GRAIL Announces Collaborations with Amgen, AstraZeneca, and Bristol Myers Squibb to Evaluate Cancer Early Detection Technology for Minimal Residual Disease

...

GRAIL Confirms Q2 2021 Introduction of Galleri, First-of-Kind Multi-Cancer Early Detection Blood Test

McKesson Ventures Expands Portfolio Development Team and Invests in Market Research

Aspen RxHealth Raises $23M Series B Funding Round Led by Bessemer Venture Partners

The Future of Care Demands a Virtual Health Ecosystem

Is the COVID Vaccine the Shot in the Arm We Need for Healthcare Access?

Andrew Dudum, Hims & Hers, on disrupting healthcare by reimagining the patient experience

McKesson Launches Ontada, an Oncology Technology and Insights Business Dedicated to Help Advance Cancer Research and Care

McKesson Ventures Invests as Clinical Ink Debuts Lunexis™ ePRO+ Solution

Michelle Snyder, Digital Health Veteran, Joins McKesson Ventures

  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104
USA

Contact Us
Cookie Settings

 

In the News

  • Through reverse auctions, Minnesota pushes for PBM savings and price transparency

  • Matternet Tests Longest Drone Delivery Route Between Hospitals and Labs in Switzerland

  • Matternet Set to Produce M2 Delivery Drones in the US After Receiving FAA Greenlight

  • I’m a doctor specializing in sexual health. There’s no ‘normal’ amount of sex you should be having — so you can stop worrying.

Subscribe to Updates via Email

Enter your email address to subscribe to McKesson Ventures updates.

©2021 McKesson Ventures | Privacy Notice | Disclaimer
@McK_Ventures
McKesson Ventures LinkedIn